- Home
- LIPO vs PRSO Comparison
LIPO vs PRSO Comparison
Compare LIPO & PRSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIPO
- PRSO
- Stock Information
- Founded
- LIPO 2005
- PRSO 2008
- Country
- LIPO United States
- PRSO United States
- Employees
- LIPO N/A
- PRSO N/A
- Industry
- LIPO Biotechnology: Pharmaceutical Preparations
- PRSO Semiconductors
- Sector
- LIPO Health Care
- PRSO Technology
- Exchange
- LIPO Nasdaq
- PRSO Nasdaq
- Market Cap
- LIPO 3.1M
- PRSO 3.3M
- IPO Year
- LIPO 2022
- PRSO 2001
- Fundamental
- Price
- LIPO $3.14
- PRSO $0.94
- Analyst Decision
- LIPO Strong Buy
- PRSO Strong Buy
- Analyst Count
- LIPO 1
- PRSO 2
- Target Price
- LIPO $16.00
- PRSO $3.38
- AVG Volume (30 Days)
- LIPO 6.6M
- PRSO 76.9K
- Earning Date
- LIPO 02-28-2025
- PRSO 03-17-2025
- Dividend Yield
- LIPO N/A
- PRSO N/A
- EPS Growth
- LIPO N/A
- PRSO N/A
- EPS
- LIPO N/A
- PRSO N/A
- Revenue
- LIPO $483,533.00
- PRSO $12,728,000.00
- Revenue This Year
- LIPO N/A
- PRSO $9.59
- Revenue Next Year
- LIPO N/A
- PRSO $1.63
- P/E Ratio
- LIPO N/A
- PRSO N/A
- Revenue Growth
- LIPO 0.78
- PRSO N/A
- 52 Week Low
- LIPO $2.21
- PRSO $0.73
- 52 Week High
- LIPO $12.00
- PRSO $2.34
- Technical
- Relative Strength Index (RSI)
- LIPO 48.05
- PRSO 50.19
- Support Level
- LIPO $3.35
- PRSO $0.82
- Resistance Level
- LIPO $4.69
- PRSO $0.92
- Average True Range (ATR)
- LIPO 0.62
- PRSO 0.07
- MACD
- LIPO -0.02
- PRSO 0.02
- Stochastic Oscillator
- LIPO 13.31
- PRSO 60.38
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
About PRSO Peraso Inc.
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.